LeBar James 4
4 · Zomedica Pharmaceuticals Corp. · Filed Jan 14, 2019
Insider Transaction Report
Form 4
LeBar James
Director
Transactions
- Award
Stock Option (right to buy)
[F1]2019-01-10+400,000→ 400,000 totalExercise: $1.52From: 2019-01-10Exp: 2021-01-10→ Common Shares, without par value (400,000 underlying)
Footnotes (1)
- [F1]The options vested upon grant. The option is currently fully vested.
Signature
/s/ John D. Hogoboom, attorney-in-fact|2019-01-14